Michelle Rowland, MD Gynecologic Oncologist, OSF HealthCare
Rare cancers demand specialized expertise, and for patients facing these diagnoses, progress can’t come fast enough.
Join us as we explore how innovation, collaboration and deep clinical focus at OSF HealthCare Cancer Institute are reshaping care for some of the most complex cancer cases. We discuss treatment of gynecologic carcinosarcomas and hepatopancreatobiliary (HPB) cancers, rare and aggressive diseases that require highly coordinated care. OSF Cancer Institute is advancing treatment through specialized surgical techniques, multidisciplinary teams and research initiatives, including clinical trials. From evolving treatment approaches to what’s coming next, the episode highlights how OSF is working to improve outcomes for patients facing daunting diagnoses.
Host Shelli Dankoff chats with Michelle Rowland, MD, a gynecologic oncologist specializing in rare uterine cancers, and Chandler Wilfong, MD, a surgeon focused on liver, pancreas and bile duct cancers. Together, they share their expertise, reflect on what drew them to these challenging specialties and discuss the impact of having comprehensive cancer resources available for patients and providers.
Michelle Rowland, MD Gynecologic Oncologist, OSF HealthCare
Chandler Wilfong, MD, Surgeon, OSF HealthCare